(Total Views: 232)
Posted On: 12/14/2021 8:25:50 AM
Post# of 74

$ABUS News Article - Antios Therapeutics and Arbutus Biopharma Announce First Patient Dosed in Phase 2a Combination Trial of ATI-2173, AB-729 and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B Virus Infection https://marketwirenews.com/news-releases/anti...53894.html


My Twitter: WhyteStocks